Progression independent of relapse activity and relapse-associated worsening in adult patients with secondary progressive multiple sclerosis

Shawky, Manar A.; Menecie, Tarek I.; Saif El Deen, Eman M.; Rashad, Mohamed H.

doi:10.21608/jram.2023.234982.1224

	Progression independent of relapse activity and relapse-associated worsening in adult patients with secondary progressive multiple sclerosis
Journal of Recent Advances in Medicine
Volume 4, Issue 2, July 2023, Page 162-168 PDF (740.12 K)
Document Type: Original Article
DOI: 10.21608/jram.2023.234982.1224
View on SCiNiTO
Authors
Manar A. Shawky ¹; Tarek I. Menecie²; Eman M. Saif El Deen³; Mohamed H. Rashad²
¹Multiple Sclerosis Unit, Neurology Department, Nasser Institute Hospital For Research and Treatment, Cairo, Egypt.
²Neurology Department, Faculty of Medicine For boys, Cairo, Al-Azhar University, Egypt.
³Neurology Department, Faculty Of Medicine For Girls, Cairo, Al-Azhar University, Egypt.
Abstract
Background: In multiple sclerosis (MS), disability may accumulate in the form of deterioration linked to relapses, known as Relapse-Associated Worsening (RAW), or through a continuous progression unaffected by relapse activity, termed Progressive Independent of Relapse Activity (PIRA). Objectives: To investigate PIRA's baseline predictors at the time of MS diagnosis and the contributions of PIRA versus RAW to the long-term clinical outcomes in secondary progressive MS (SPMS) patients. Methodology: A retrospective cohort study was conducted at Nasser institute hospital on 150 patients with SPMS. Baseline and clinical data were collected during MS diagnosis, progression data during the disease course, and further outcome data. Also, different disability scores associated with PIRA and RAW were performed. Results: Of 150 SPMS patients, 90 had PIRA, and 60 had RAW. Only age and type of relapses before starting disease modifying drugs (DMDs) showed significant differences between the groups. Patients with PIRA had higher mean age (40.1 ± 5.1 vs. 38.3 ± 5.43, p = 0.04) and fewer vision relapses than patients with RAW (34.4% vs. 51.7%, respectively p = 0.036). Moreover, no differences were found in magnetic resonance imaging (MRI) findings, including lesions and oligoclonal bands. There were significant associations between PIRA and poor long-term outcomes indicated by expanded disability status scale (EDSS), simple digit modalities test (SDMT), and 25-foot timed walk test (25FWT). Conclusion: After the initial diagnosis of PIRA manifesting multiple sclerosis is prevalent among patients who develop secondary progression and indicates an unfavorable long-term prognosis. However, the prediction of PIRA is challenging, and further prospective research is warranted.
Keywords
Expanded disability status scale (EDSS ); multiple sclerosis (MS); relapse-associated worsening (RAW); secondary progressive MS (SPMS); progression independent of relapse activity (PIRA)


Statistics Article View: 169 PDF Download: 227